USC-Brookings Schaeffer Initiative for Health Policy
Other featured articles
Healthcare Price Regulation and Public Options: Assessing Approaches to Increasing the Public Role
Part 2 of a panel series on healthcare price regulation honoring Uwe E. Reinhardt (1937-2017)
Sharing Drug Rebates With Medicare Part D Patients: Why And How
The percentage of total Medicare Part D drug spending offset by rebates on branded drugs increased from 11% in 2010 to 25% in 2018.
AJMC: Policies to Address Surprise Billing Can Affect Health Insurance Premiums
This study, published in the American Journal of Managed Care, finds policies to address surprise billing could reduce health insurance premiums by 1% to 5%. A press release about the study is available here. We leveraged 2017 commercial claims data from the Health Care Cost Institute, comprising 568.5 million claims from 44.8 million covered lives […]
How Surprise Billing Increases Premiums—and How New Policies Could Help Consumers
A USC-Brookings Schaeffer Initiative for Health Policy research team finds that policies to limit surprise billing could also reduce insurance premiums for Americans by billions each year.
About this section
The USC-Brookings Schaeffer Initiative for Health Policy is a partnership between Economic Studies at Brookings and the USC Schaeffer Center for Health Policy & Economics, and aims to inform the national health care debate with rigorous, evidence-based analysis leading to practical recommendations using the collaborative strengths of USC and Brookings.